InvestorsHub Logo
Followers 65
Posts 2132
Boards Moderated 0
Alias Born 02/26/2014

Re: None

Monday, 10/05/2015 8:40:04 PM

Monday, October 05, 2015 8:40:04 PM

Post# of 2337616
****PPCH***** DD*******

Propanc (PPCH) is a stock to keep a close eye on as they are currently completing their pre-clinical animal studies (testing on animals before humans, as prescribed by the FDA’s process) which would then potentially be used to apply to the FDA to start human clinical trials through a new drug application (NDA). As the animal studies unfold, the Company should continually release the news- they have stated these studies could be completed by year-end which would allow us to assume that the important news regarding safety and efficacy could be coming in the coming weeks. From there, they plan to conduct meetings with several regulatory agencies including the FDA to present their preclinical data and discuss the formal GLP animal safety studies and early stage clinical development pathway as they seek to proceed their lead product into human trials next year. Interestingly, pharmaceutical stocks benefit most in the early stages of their drug’s development so the Company’s and stock should be watched closely in the coming days and weeks.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.